This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Francesco Roncato: Innovator in Synthetic Embryo Generation
Introduction
Francesco Roncato is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of synthetic biology, particularly in the generation of synthetic embryos. His innovative work has the potential to advance research in developmental biology and regenerative medicine.
Latest Patents
Roncato holds a patent for "Methods of generating a synthetic embryo." This patent outlines a method that involves inducing the expression of specific factors to differentiate naïve pluripotent stem cells (PSCs) into trophectoderm primed cells and extra embryonic primitive endodermal primed cells. The process culminates in mixing these differentiated cells with naïve PSCs to form aggregated cells. This groundbreaking method opens new avenues for research and application in synthetic embryo generation.
Career Highlights
Francesco Roncato is associated with Yeda Research and Development Company Ltd. His work at this esteemed institution has allowed him to explore innovative methodologies in synthetic biology. With a focus on the intersection of technology and biology, Roncato continues to push the boundaries of what is possible in the field.
Collaborations
Roncato has collaborated with notable colleagues, including Yaqub Hanna and Segev Naveh Tassa. These partnerships have fostered a collaborative environment that enhances the research and development of synthetic embryo technologies.
Conclusion
Francesco Roncato's contributions to the field of synthetic biology, particularly through his patent on synthetic embryo generation, highlight his role as an innovator. His work not only advances scientific understanding but also paves the way for future developments in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile